Yusra Habib Khan1,2, Azmi Sarriff3, Azreen Syazril Adnan4, Amer Hayat Khan3, Tauqeer Hussain Mallhi3,4. 1. School of Pharmaceutical Sciences, University Sains Malaysia, 11800, Penang, Malaysia. yusrahabib@ymail.com. 2. Chronic Kidney Disease Resource Centre, School of Medical Sciences, Health Campus, University Sains Malaysia, 16150, Kota Bharu, Kelantan, Malaysia. yusrahabib@ymail.com. 3. School of Pharmaceutical Sciences, University Sains Malaysia, 11800, Penang, Malaysia. 4. Chronic Kidney Disease Resource Centre, School of Medical Sciences, Health Campus, University Sains Malaysia, 16150, Kota Bharu, Kelantan, Malaysia.
Abstract
INTRODUCTION: The relationship between hypertension and fluid overload in pre-dialysis CKD patients need to be elucidated. Current study aimed to find relationship between fluid overload and hypertension along with prescribed diuretic therapy using bioimpedance spectroscopy (BIS). METHODOLOGY: A prospective observational study was conducted by inviting pre-dialysis CKD patients. Fluid overload was assessed by BIS. RESULTS: A total of 312 CKD patients with mean eGFR 24.5 ± 11.2 ml/min/1.73 m2 were enrolled. Based on OH value ≥7 %, 135 (43.3 %) patients were hypervolemic while euvolemia was observed in 177 (56.7 %) patients. Patients were categorized in different regions of hydration reference plot (HRP) generated by BIS i.e., 5.1 % in region-N (normal BP and fluid status), 20.5 % in region I (hypertensive with severe fluid overload), 29.5 % in region I-II (hypertensive with mild fluid overload), 22 % in region II (hypertensive with normohydration), 10.2 % in region III (underhydration with normal/low BP) and 12.5 % in region IV (normal BP with severe fluid overload). A total of 144 (46 %) patients received diuretics on basis of physician assessment of BP and edema. Maximum diuretics 100 (69.4 %) were prescribed in patients belonging to regions I and I-II of HRP. Interestingly, a similar number of diuretic prescriptions were observed in region II (13 %) and region IV (12 %). Surprisingly, 7 (4.9 %) of patients in region III who were neither hypervolemic nor hypertensive were also prescribed with diuretics. CONCLUSION: BIS can aid clinicians to categorize CKD patients on basis of their fluid status and provide individualized pharmacotherapy to manage hypertensive CKD patients.
INTRODUCTION: The relationship between hypertension and fluid overload in pre-dialysis CKDpatients need to be elucidated. Current study aimed to find relationship between fluid overload and hypertension along with prescribed diuretic therapy using bioimpedance spectroscopy (BIS). METHODOLOGY: A prospective observational study was conducted by inviting pre-dialysis CKDpatients. Fluid overload was assessed by BIS. RESULTS: A total of 312 CKDpatients with mean eGFR 24.5 ± 11.2 ml/min/1.73 m2 were enrolled. Based on OH value ≥7 %, 135 (43.3 %) patients were hypervolemic while euvolemia was observed in 177 (56.7 %) patients. Patients were categorized in different regions of hydration reference plot (HRP) generated by BIS i.e., 5.1 % in region-N (normal BP and fluid status), 20.5 % in region I (hypertensive with severe fluid overload), 29.5 % in region I-II (hypertensive with mild fluid overload), 22 % in region II (hypertensive with normohydration), 10.2 % in region III (underhydration with normal/low BP) and 12.5 % in region IV (normal BP with severe fluid overload). A total of 144 (46 %) patients received diuretics on basis of physician assessment of BP and edema. Maximum diuretics 100 (69.4 %) were prescribed in patients belonging to regions I and I-II of HRP. Interestingly, a similar number of diuretic prescriptions were observed in region II (13 %) and region IV (12 %). Surprisingly, 7 (4.9 %) of patients in region III who were neither hypervolemic nor hypertensive were also prescribed with diuretics. CONCLUSION: BIS can aid clinicians to categorize CKDpatients on basis of their fluid status and provide individualized pharmacotherapy to manage hypertensiveCKDpatients.
Authors: S Wieskotten; S Heinke; P Wabel; U Moissl; J Becker; M Pirlich; M Keymling; R Isermann Journal: Physiol Meas Date: 2008-05-07 Impact factor: 2.833
Authors: Akshay S Desai; Robert Toto; Petr Jarolim; Hajime Uno; Kai-Uwe Eckardt; Reshma Kewalramani; Andrew S Levey; Eldrin F Lewis; John J V McMurray; Hans-Henrik Parving; Scott D Solomon; Marc A Pfeffer Journal: Am J Kidney Dis Date: 2011-08-05 Impact factor: 8.860
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson Journal: Circulation Date: 2003-10-28 Impact factor: 29.690
Authors: David Naranjo-Hernández; Javier Reina-Tosina; Laura M Roa; Gerardo Barbarov-Rostán; Nuria Aresté-Fosalba; Alfonso Lara-Ruiz; Pilar Cejudo-Ramos; Francisco Ortega-Ruiz Journal: Sensors (Basel) Date: 2019-12-21 Impact factor: 3.576
Authors: Sang Heon Suh; Tae Ryom Oh; Hong Sang Choi; Chang Seong Kim; Eun Hui Bae; Kook-Hwan Oh; Kyu-Beck Lee; Seung Hyeok Han; Suah Sung; Seong Kwon Ma; Soo Wan Kim Journal: Front Cardiovasc Med Date: 2022-01-26